This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Fezolinetant

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fezolinetant

  • developed for the treatment of moderate-to-severe vasomotor symptoms associated with menopause
  • is a nonhormonal, selective neurokinin 3 receptor antagonist that blocks neurokinin B binding on the kisspeptin/neurokinin B/dynorphin neurons in the hypothalamus to moderate neuronal activity in the thermoregulatory center
  • is a once-daily oral nonhormonal therapy
  • a review (n=2168;5 RCTs) found fezolinetant is effective in lowering moderate-to-severe vasomotor symptom frequency (pooled mean difference of 2.62 [95% CI 1.84-3.41] episodes per day versus placebo) and was associated with improvement in sleep quality (3)
  • possible adverse effects of fezolinetant include diarrhoea, insomnia, abdominal pain and an increase in alanine transaminase (4)

Reference:

  1. Neal-Perry G, Cano A, Lederman S, Nappi RE, Santoro N, Wolfman W, English M, Franklin C, Valluri U, Ottery FD. Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstet Gynecol. 2023 Apr 1;141(4):737-747
  2. Wright AC, Beaudoin FL, McQueen RB, Yeung K, Moradi A, Herron-Smith S, Gutierrez E, Lin GA, Pearson SD. The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review's Midwest Public Advisory Council. J Manag Care Spec Pharm. 2023 Jun;29(6):692-698.
  3. Bonga KN et al. Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis. Obstetrics & Gynecology ():10.1097/AOG.0000000000005508, January 16, 2024.
  4. Fezolinetant for menopausal vasomotor symptomsDrug and Therapeutics Bulletin 2024;62:118-124

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.